Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) To Webcast Business Update In Advance Of 25th Annual JPMorgan Healthcare Conference

CAMBRIDGE, Mass., Dec. 29 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM - News) will hold a live webcast of a conference call at 8:00 a.m. EST on Friday, January 5, 2007 in advance of the 25th Annual JPMorgan Healthcare Conference. Dr. Deborah Dunsire, president and chief executive officer of Millennium, will host the call. She will discuss the Company's key accomplishments in 2006 and goals and financial guidance for 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

The live webcast can be accessed by visiting the Investors section of the Company's website, www.millennium.com. Following the webcast, an archived version of the call will be available at the same address for 30 days.

About Millennium

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE® (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company's website is www.millennium.com.

Editors' Note: This press release is also available under the Media section of the Company's website at: www.millennium.com.

Contact:

Kyle Kuvalanka

(617) 761-4734

Source: Millennium Pharmaceuticals, Inc.